Search filters

Filters
Clear All

Phase

  • 20
  • 28
  • 1
  • 27
  • 1
  • 20
  • 8
  • 252
  • 372
  • 175
  • 4
  • 23
  • 346

Found 373 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18-99 years
All genders
Phase 1
Interventional
The research study is being conducted to determine if a same-day intravenous (into a vein) injection of indocyanine green (ICG) detected using an imaging system, can be a useful tool in identifying and differentiating tumor tissue from normal tissues.
18-99 years
All genders
Phase 2
Interventional
The purpose of this study are to determine the maximum dose of FF-10832 that can be tolerated when taken in combination with pembrolizumab and to determine whether FF10832 taken by itself or in combination with pembrolizumab has anti-tumor activity.
99 years and younger
All genders
This study will look at the efficacy, safety, and tolerability of itepekimab, in people with non-cystic fibrosis bronchiectasis. Patients will be asked to complete a CT, lab tests, safety labs, lung function tests, PEs, ECGs, and questionnaires.
99 years and younger
All genders
Primary Objective: To determine if CONDUIT and PEEK +rhBMP-2 cages produce similar clinical and radiographic outcomes in patients undergoing direct lateral Interbody fusion Secondary Objective: To determine if CONDUIT and PEEK + rhBMP-2 cages are comparable with regards to cost The primary study endpoint will be the difference in fusion …
 Phase I Clinical Trial of Adoptive Transfer of Autologous Folate Receptor alpha Redirected T Cells for Recurrent High Grade Serous Ovarian  Fallopian Tube  or Primary Peritoneal Cancer
99 years and younger
All genders
Phase 1
This is a Phase I study evaluating the safety and feasibility of intraperitoneal administered lentiviral transduced MOv19-BBz CAR-T cells in 4 cohorts with or without cyclophosphamide + fludarabine in a 3+3 dose escalation design. Up to 18 evaluable subjects will be treated.
99 years and younger
All genders
PURPOSE We aim to conduct a prospective observational study to test the central hypothesis that myocardial LM begins early after STEMI, as a response to myocardial hemorrhage and reperfusion injury, and determines future susceptibility to malignant arrhythmia. Study participants will be 175 (allowing for 25 dropouts) men and women 2 …
 Technology for Detection of SARS-Cov-2 in HIV-Positive Cancer Patients
99 years and younger
All genders
The main purpose of this study is to try a new type of laboratory test for COVID-19 (also called SARS-CoV-2 or novel coronavirus).  COVID-19 is a new disease, so not enough is known about it yet.  This study hopes to collect more information about who is most as risk from …
 Brain Arterio-Venous Metabolomic Profiling
18-99 years
All genders
The research study is being conducted to better understand brain metabolism, i.e. how the brain uses and consumes the various nutrients that are available in the blood. Changes in brain metabolism have been implicated in dementia and psychiatric disorders, as well as short- and long-term outcomes of traumatic brain injury …
99 years and younger
All genders
This study evaluates the effects (good or bad) of adding a study drug (duvelisib or CC-486 (azacitidine)) to the usual combination of drugs. Eligible participants will be those with stage I-IV CD30 negative peripheral T-cell lymphoma that has not been previously treated.
99 years and younger
All genders
This is a substudy of an umbrella study (MK-3475-U1). Subjects will be enrolled to the screening protocol and then subsequently enrolled to one of the substudies. This substudy examines MK-4830 in combination with pembrolizumab in participants with PD-L1 positive NSCLC.
211 - 220 of 373